Spots Global Cancer Trial Database for Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck
Official Title: A 2 Part Phase 2 Trial to Evaluate ZD1839 (Iressa™) & Radiotherapy in Patients w/Locally Advanced Inoperable Squamous Cell Carcinoma of the Head & Neck
Study ID: NCT00233636
Study Description
Brief Summary: The aim of the study is to determine if Iressa added to radiotherapy is effective and safe in shrinking tumour dimensions.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, Aviano, , Italy
Research Site, Azienda, , Italy
Research Site, Milano, , Italy
Research Site, Napoli, , Italy
Research Site, Palermo, , Italy
Research Site, Ragusa, , Italy
Contact Details
Name: AstraZeneca Italy Medical Director, MD
Affiliation: AstraZeneca
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
